The immunotherapy medicine Keytruda (chemical name: pembrolizumab) along with chemotherapy offered better progression-free survival than chemotherapy alone as the first treatment for metastatic triple-negative breast cancer or...
Results from two studies on using the immunotherapy medicines Tecentriq (chemical name: atezolizumab) or Keytruda (chemical name: pembrolizumab) along with chemotherapy to treat early-stage triple-negative breast cancer before surgery...
On Nov. 13, 2020, the U.S. Food and Drug Administration (FDA) approved the immunotherapy Keytruda (chemical name: pembrolizumab) in combination with chemotherapy to treat unresectable locally advanced or metastatic triple-negative,...
The combination of the immunotherapy Keytruda (chemical name: pembrolizumab) and chemotherapy before surgery to remove early-stage, triple-negative breast cancer led to a better pathologic complete response than chemotherapy alone,...
Immunotherapy medicines use the power of your body’s immune system to attack cancer cells. Cancer immunotherapy medicines work by helping your immune system work harder or more efficiently to fight cancer cells. Immunotherapy uses...
On July 26, 2021, the U.S. Food and Drug Administration (FDA) approved the immunotherapy medicine Keytruda (chemical name: pembrolizumab) plus chemotherapy before surgery, followed by Keytruda alone after surgery to treat early-stage...
The Breast Cancer Index test, made by Biotheranostics, analyzes the activity of 11 genes to help predict the risk of early-stage, hormone-receptor-positive breast cancer coming back 5 to 10 years after diagnosis. The test can help women...
Brand name: Keytruda Chemical name: Pembrolizumab Class: PD-L1 immune checkpoint inhibitor How it works: PD-1 is a checkpoint protein on T cells, immune system cells that attack foreign invaders in the body. PD-L1 is another checkpoint...
Keytruda (chemical name: pembrolizumab) is approved by the U.S. Food and Drug Administration (FDA) to be used: in combination with chemotherapy to treat unresectable locally advanced or metastatic triple-negative, PD-L1-positive breast...
Immunotherapy medicines use the power of your body’s immune system to attack cancer cells. There are several immunotherapy medicines approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer. Immune checkpoint...
Treatment with the immunotherapy medicine Keytruda (chemical name: pembrolizumab) plus chemotherapy before surgery, followed by Keytruda alone after surgery improved event-free survival better than chemotherapy alone in women diagnosed...
Breast cancer screening rates dropped dramatically at the beginning of the COVID-19 pandemic, especially among women of certain racial and ethnic groups, as well as women living in rural areas, according to a U.S. Centers for Disease...
A new study by Fergus Couch, Ph.D., of Mayo Clinic Cancer Center, along with collaborators from the CARRIERS consortium, suggests that most women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic testing.
The Eunice Kennedy Shriver National Institute of Child Health & Human Development has awarded a $256,000 grant to BioAesthetics Corp., a Tulane University spin-out company, to develop a new graft for treating pelvic organ prolapse (POP).
An innovative testing platform that more closely mimics what cancer encounters in the body may allow for more precise, personalized therapies by enabling the rapid study of multiple therapeutic combinations against tumor cells.
A new approach to treating breast cancer kills 95 to 100 percent of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called...
A protein involved in making cells move offers a clue to how certain types of cancer metastasize and develop into secondary tumors, according to new research from the University of Warwick.
A research team led by Fumito Ito, MD, PhD, FACS, of Roswell Park Comprehensive Cancer Center reports new data on the promise of combining standard treatment for breast cancer with a particular form of cancer immmunotherapy -;...
Being a member of the Breastcancer.org team provides you with the opportunity to be a part of a very special group of people doing extraordinary work. As a member of our team, you will play an important role in delivering vital...
As a member of the Breastcancer.org team, you will have the opportunity to be a part of a diverse and talented group of people doing extraordinary work together. We believe in celebrating our unique differences and coming together for...
Tens of millions of patients around the world suffer from persistent and potentially life-threatening wounds. These chronic wounds, which are also a leading cause of amputation, have treatments, but the cost of existing wound dressings...
The COVID-19 pandemic knocked many women off schedule for important health appointments, a new study finds, and many didn't get back on schedule even after clinics reopened. The effect may have been greatest in areas where such care is...
A Ludwig Cancer Research study has found that inducing random chromosome instability (CIN) events in mice for as little as one week is enough to trigger harmful chromosomal patterns in cells that spur the formation of tumors.
UC Davis Comprehensive Cancer Center received a $50,000 grant from the Safeway Foundation to explore the use of the South Asian spice Turmeric as a way of reducing joint pain in breast cancer patients being treated with anti-estrogen drugs.
In December 2020, the U.S. Food and Drug Administration (FDA) authorized the first COVID-19 vaccines for emergency use: the Pfizer-BioNTech COVID-19 vaccine and the Moderna COVID-19 vaccine. The Johnson & Johnson (J&J) COVID-19...
Unless people experience breast cancer in their own lives, or they’re close to someone who does, they might not be able to separate myth from fact when it comes to this disease: who gets it and why, for example, or what treatment...
A new study has found an association between alcohol and a substantially higher risk of several forms of cancer, including breast, colon, and oral cancers. Increased risk was evident even among light to moderate drinkers (up to two...
Researchers behind estimate say more needs to be done to raise public awareness of link Alcohol is estimated to have caused more than 740,000 cancer cases around the world last year, and experts say more needs to be done to highlight the...
Breast cancer death rates decreased among all racial and ethnic groups from 1990 to 2015 in Florida, according to a study. But from 2010 to 2015, Black women were still twice as likely to die from breast cancer as white women. The...
Multiparametric MRI scan involves flexible scanning coil, and is quicker than traditional MRI More detailed MRI to detect early breast cancer begins UK trials Lying in an MRI scanner is cold and noisy at the best of times, and if you’re...
Exclusive: multiparametric MRI designed to be more comfortable and effective in early detection New breast cancer scan is designed with women’s comfort in mind A new, more comfortable way of detecting breast cancer, which could enable...
Every June, the American Society of Clinical Oncology Annual Meeting brings together clinicians, researchers, and advocates to discuss the latest cancer study results. We’re proud to present our coverage below. Research News:...
A recent study has shown that the shape of cell-derived nanoparticles, known as 'extracellular vesicles' (EVs), in body fluids could be a biomarker for identifying types of cancer. In the study, scientists successfully measured the shape...
Researchers have developed a promising new cancer immunotherapy that uses cancer-killing cells genetically engineered outside the body to find and destroy malignant tumors.
Charity warns 10,600 fewer women started treatment for the disease in past year, compared with year before Coronavirus – latest updates See all our coronavirus coverage Progress in reducing breast cancer deaths may be under threat, a...
Scientists studying the link between cholesterol and breast cancer report that a byproduct of cholesterol metabolism causes some cells to send out cancer-promoting signals to other cells. These signals are packaged in membrane-bound...
A new treatment has potential to improve the outcomes for patients with hereditary BRCA mutations and high-risk, early-stage breast cancer. These results represent the first time a PARP inhibitor has been shown to significantly reduce...
Researchers have unveiled important new insights into how hormones known as androgens act on our cells - and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers.
When she was told she had stage four breast cancer in 2009, Hallenga didn’t even know it could be a danger at her age. Then she started a campaign to save thousands of lives Eight months before Kris Hallenga was diagnosed with stage four...
Higher mushroom consumption is associated with a lower risk of cancer, according to a new study. The systematic review and meta-analysis examined 17 cancer studies published from 1966 to 2020. Analyzing data from more than 19,500 cancer...
Exposure to certain endocrine-disrupting chemicals could elevate the risk of breast cancer, according to a new comprehensive systematic review of epidemiological research. However, for many chemicals, evidence is inconsistent or still...
Intraoperative radiotherapy with electrons (IOERT) boost could be not inferior to external beam radiotherapy (EBRT) boost in terms of local control and tissue tolerance. The aim of the study is to present the ...
An abundance of tumor-associated macrophages has been shown to be an independent prognostic factor for a poor prognosis of human breast cancer (BC). Adipose tissue accounts for the largest proportion of the br...
Researchers have found that blocking a specific protein could increase tumor sensitivity to treatment with PARP inhibitors. Their work suggests combining treatments could lead to improved therapy for patients with inheritable breast...